Phase I/IIa study of BB-HB-331 in patients with Hepatitis-B

Trial Profile

Phase I/IIa study of BB-HB-331 in patients with Hepatitis-B

Planning
Phase of Trial: Phase I/II

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs BB-HB 331 (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2016 According to Benitec pipeline, this trial is expected to initiate by Q4 2017.
    • 14 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top